According to research, Britain must vaccinate two million a week to avoid a third wave of COVID-19

(Reuters) – Britain must vaccinate two million people a week to prevent a third wave of the coronavirus outbreak, a study from the London School of Hygiene and Tropical Medicine (LSHTM) concludes.

According to a Reuters report, there were more than 71,000 deaths from the coronavirus and more than 2.3 million cases of COVID-19 infections in the UK at the end of Monday, according to a report by Reuters.

“The most stringent intervention scenario with tier 4 (restrictions) England-wide and schools closed in January and 2 million individuals vaccinated per week is the only scenario we have considered that the peak load in the ICU (intensive care unit) ) diminishes below the level seen during the first wave, ”the study said.

“In the absence of a substantial rollout of vaccines, cases, hospitalizations, ICU admissions and deaths in 2021 could be greater than in 2020.”

An accelerated intake of two million vaccinees per week “is expected to have a much greater impact,” bit.ly/3o9l2MJ added. The study has yet to be peer reviewed.

In response to the study, a UK health department spokesperson told Reuters that “vaccination coverage will increase in the coming weeks and months as millions more doses become available and the program continues to expand.”

The UK government has said it has obtained early access to 357 million doses of vaccines through agreements with several developers.

Prime Minister Boris Johnson and his scientific advisers have said that a variant of the coronavirus, which could be up to 70% more transmissible, is spreading rapidly in Britain, although it is not thought to be more deadly or cause more serious disease.

That led to strict social mixing restrictions for London and South East England, while plans to lighten curbs across the country during Christmas were either drastically scaled back or scrapped altogether.

According to media reports over the weekend, Britain will launch the Oxford-AstraZeneca COVID-19 vaccine starting January 4, with approval by the country’s medical regulator expected in days.

Earlier this month, Britain became the first country in the world to market the vaccine from Pfizer and BioNTech.

The British government said on Thursday that 600,000 people had received the first dose of the Pfizer-BioNTech COVID-19 vaccine.